95 related articles for article (PubMed ID: 28302043)
1. CUL5 and APOBEC3G Polymorphisms are Partially Implicated in HIV-1 Infection and Antiretroviral Therapy in a Brazilian Population.
da Silva RC; Coelho AVC; de Moura RR; Arraes LC; Brandão LAC; Guimarães RL; Crovella S
Curr HIV Res; 2017; 15(4):245-257. PubMed ID: 28302043
[TBL] [Abstract][Full Text] [Related]
2. Association of single nucleotide polymorphisms of APOBEC3G with susceptibility to HIV-1 infection and disease progression among men engaging in homosexual activity in northern China.
Li Q; Qiao Y; Zhang G; He N; Zhang X; Jia X; Sun H; Wang C; Xu L
Arch Virol; 2017 Jan; 162(1):259-268. PubMed ID: 27730383
[TBL] [Abstract][Full Text] [Related]
3. Effect of HIV-1 Vif variability on progression to pediatric AIDS and its association with APOBEC3G and CUL5 polymorphisms.
De Maio FA; Rocco CA; Aulicino PC; Bologna R; Mangano A; Sen L
Infect Genet Evol; 2011 Aug; 11(6):1256-62. PubMed ID: 21571098
[TBL] [Abstract][Full Text] [Related]
4. HLA-C Single Nucleotide Polymorphism Associated with Increased Viral Load Level in HIV-1 Infected Individuals from Northeast Brazil.
Celerino da Silva R; Moura RR; Victor Campos Coelho A; Arraes LC; Brandão LAC; Crovella S; Lima Guimarães R
Curr HIV Res; 2017; 15(4):266-272. PubMed ID: 28494720
[TBL] [Abstract][Full Text] [Related]
5. APOBEC3G/3A Expression in Human Immunodeficiency Virus Type 1-Infected Individuals Following Initiation of Antiretroviral Therapy Containing Cenicriviroc or Efavirenz.
Covino DA; Purificato C; Catapano L; Galluzzo CM; Gauzzi MC; Vella S; Lefebvre E; Seyedkazemi S; Andreotti M; Fantuzzi L
Front Immunol; 2018; 9():1839. PubMed ID: 30135687
[TBL] [Abstract][Full Text] [Related]
6. HBV/HIV co-infection and APOBEC3G polymorphisms in a population from Burkina Faso.
Compaore TR; Diarra B; Assih M; Obiri-Yeboah D; Soubeiga ST; Ouattara AK; Tchelougou D; Bisseye C; Bakouan DR; Compaore IP; Dembele A; Djigma WF; Simpore J
BMC Infect Dis; 2016 Jul; 16():336. PubMed ID: 27449138
[TBL] [Abstract][Full Text] [Related]
7. Evaluating the contribution of APOBEC3G haplotypes, on influencing HIV infection in a Zimbabwean paediatric population.
Mhandire K; Duri K; Mhandire D; Musarurwa C; Stray-Pedersen B; Dandara C
S Afr Med J; 2016 May; 106(6 Suppl 1):S119-23. PubMed ID: 27245545
[TBL] [Abstract][Full Text] [Related]
8. APOBEC3-mediated editing in HIV type 1 from pediatric patients and its association with APOBEC3G/CUL5 polymorphisms and Vif variability.
De Maio FA; Rocco CA; Aulicino PC; Bologna R; Mangano A; Sen L
AIDS Res Hum Retroviruses; 2012 Jun; 28(6):619-27. PubMed ID: 22145963
[TBL] [Abstract][Full Text] [Related]
9. APOBEC3G expression is dysregulated in primary HIV-1 infection and polymorphic variants influence CD4+ T-cell counts and plasma viral load.
Reddy K; Winkler CA; Werner L; Mlisana K; Abdool Karim SS; Ndung'u T;
AIDS; 2010 Jan; 24(2):195-204. PubMed ID: 19996938
[TBL] [Abstract][Full Text] [Related]
10. Correlation of Apolipoprotein B mRNA-editing Enzyme, Catalytic Polypeptide- like 3G Genetic Variant rs8177832 with HIV-1 Predisposition in Pakistani Population.
Iqbal K; Imran M; Ullah S; Jamal M; Waheed Y
Curr HIV Res; 2018; 16(4):297-301. PubMed ID: 30338740
[TBL] [Abstract][Full Text] [Related]
11. Induction of APOBEC3G ubiquitination and degradation by an HIV-1 Vif-Cul5-SCF complex.
Yu X; Yu Y; Liu B; Luo K; Kong W; Mao P; Yu XF
Science; 2003 Nov; 302(5647):1056-60. PubMed ID: 14564014
[TBL] [Abstract][Full Text] [Related]
12. Polymorphisms of CUL5 are associated with CD4+ T cell loss in HIV-1 infected individuals.
An P; Duggal P; Wang LH; O'Brien SJ; Donfield S; Goedert JJ; Phair J; Buchbinder S; Kirk GD; Winkler CA
PLoS Genet; 2007 Jan; 3(1):e19. PubMed ID: 17257057
[TBL] [Abstract][Full Text] [Related]
13. Coding region variant 186H/R in Exon 4 of APOBEC3G among individuals of Western India.
Singh H; Marathe S; Nain S; Nema V; Angadi M; Bapat S; Pawar J; Ghate M; Sahay S; Gangakhedkar RR
APMIS; 2016 May; 124(5):401-5. PubMed ID: 26853443
[TBL] [Abstract][Full Text] [Related]
14. Combination of low producer AA-genotypes in IFN-γ and IL-10 genes makes a high risk genetic variant for HIV disease progression.
Singh S; Sharma A; Arora SK
Cytokine; 2016 Jan; 77():135-44. PubMed ID: 26579633
[TBL] [Abstract][Full Text] [Related]
15. APOBEC3G levels predict rates of progression to AIDS.
Jin X; Wu H; Smith H
Retrovirology; 2007 Mar; 4():20. PubMed ID: 17374143
[TBL] [Abstract][Full Text] [Related]
16. ISG15 expression correlates with HIV-1 viral load and with factors regulating T cell response.
Scagnolari C; Monteleone K; Selvaggi C; Pierangeli A; D'Ettorre G; Mezzaroma I; Turriziani O; Gentile M; Vullo V; Antonelli G
Immunobiology; 2016 Feb; 221(2):282-90. PubMed ID: 26563749
[TBL] [Abstract][Full Text] [Related]
17. APOBEC3G mRNA expression in exposed seronegative and early stage HIV infected individuals decreases with removal of exposure and with disease progression.
Vázquez-Pérez JA; Ormsby CE; Hernández-Juan R; Torres KJ; Reyes-Terán G
Retrovirology; 2009 Mar; 6():23. PubMed ID: 19254362
[TBL] [Abstract][Full Text] [Related]
18. Loci polymorphisms of the APOBEC3G gene in HIV type 1-infected Brazilians.
Bizinoto MC; Leal E; Diaz RS; Janini LM
AIDS Res Hum Retroviruses; 2011 Feb; 27(2):137-41. PubMed ID: 20874421
[TBL] [Abstract][Full Text] [Related]
19. Anti-APOBEC3G activity of HIV-1 Vif protein is attenuated in elite controllers.
Kikuchi T; Iwabu Y; Tada T; Kawana-Tachikawa A; Koga M; Hosoya N; Nomura S; Brumme ZL; Jessen H; Pereyra F; Trocha A; Walker BD; Iwamoto A; Tokunaga K; Miura T
J Virol; 2015 May; 89(9):4992-5001. PubMed ID: 25717111
[TBL] [Abstract][Full Text] [Related]
20. Occurrence of APOBEC3G variations in West Indian HIV patients.
Singh H; Gangakhedkar RR
Microb Pathog; 2018 Aug; 121():325-330. PubMed ID: 29864532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
